Pharmafile Logo
Pharmafocus logo
Advanced Search

Lonza

Showing 15 posts of 55 posts found.

Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn

March 20, 2024
Manufacturing and Production Lonza, Pharmacy, Roche, biologics, facility, manufacturing

Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics site based in Vacaville, California, …

News

Lonza to acquire Synaffix to strengthen ADC development

June 1, 2023
Medical Communications ADC, Lonza, Oncology, Synaffix, drug development

Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …

News
moderna_norwood_plant

Moderna submits BLA with FDA for COVID vaccine

June 2, 2021
Research and Development COVID-19, EU, FDA, Lonza, Moderna, production

Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …

News
lonza

Lonza to invest over £150 million on new molecule complex

April 23, 2021
Medical Communications Lonza

Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …

News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021
Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

News
funk

Lonza CEO to step down in 2020

November 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, appointment

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to step down from the role …

News
richard_ridinger

Richard Ridinger resigns from CEO position at Lonza causing shares to plummet

January 30, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …

Appointment

Lonza cleared to acquire Capsugel in $5.5 billion deal

June 28, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition

Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …

News

Sanofi and Lonza partner up for €270m biologics facility

February 28, 2017
Manufacturing and Production Lonza, Sanofi

Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …

News
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …

News

Lonza grows manufacturing capability by opening further site

November 4, 2016
Medical Communications Lonza, drug product services, manufacturing

Lonza, a Swiss multinational chemical and biotechnology company, has opened a new manufacturing facility in Basel, where their headquarters is …

News
Lonza image

TiGenix and Lonza partner on stem cell manufacturing

February 13, 2015
Manufacturing and Production, Sales and Marketing Crohn’s disease, Lonza, Stem cells, TiGenix, crohn's disease, eascs, manufacturing, spa

Stem cell therapy developer TiGenix has enlisted the help of biologics manufacturer Lonza to produce its medicine Cx601 for late-stage …

News
Lonza image

BMS and Lonza announce expansion plans

October 31, 2014
Manufacturing and Production, Sales and Marketing BMS, Lonza, Orencia, manufacturing, opdivo

Bristol-Myers Squibb (BMS) and Lonza are to expand upon an existing manufacturing agreement to meet anticipated demand for commercial biologics. …

News
sven_abend

Lonza adds executive committee member

June 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, sven Abend

Sven Abend is joining Swiss chemicals and biotech giant Lonza to serve on its executive committee. From July Abend will …

Appointment
screen_shot_2014-04-30_at_08

Lonza makes change at the top

April 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, funk

Swiss pharma supplier firm Lonza has confirmed a leadership change as its chief operating officer (COO) leaves.  Marc Funk has …

Appointment

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024